Clinical Trials Browser

Withdrawn × Multiple Myeloma × Bendamustine Hydrochloride × Clear all

NCT02315157 2025-10-15

Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma

Phase 1 Withdrawn

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma

NCT01332617 2017-12-29

Phase II Study of Simvastatin for Relapsed/Refractory Myeloma

Phase 2 Withdrawn

Multiple Myeloma, Neoplasms, Plasma Cell